Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studies
Abstract The pharmacokinetics and potential drug-drug interactions between cetuximab and cisplatin or carboplatin from two studies (JXBA and JXBB) were evaluated. These studies were multicenter, open‐label phase II trials designed to evaluate the drug-drug interactions between cetuximab (400 mg m−2...
Saved in:
Main Authors: | Raymond P. Perez (Author), Eric Chen (Author), J. Thaddeus Beck (Author), Keisuke Shirai (Author), David Neil Hayes (Author), Tong Shen (Author), John R. Baldwin (Author), Katherine B. Bryant (Author), Shuang He (Author), Steve Chin (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Cetuximab in Combination with Cisplatin and Adjuvant Pelvic Radiation for Stage IIIB Vulvar Carcinoma
by: Jennifer Bergstrom, et al.
Published: (2015) -
NOX66 as Monotherapy, and in Combination With Carboplatin, in Patients With Refractory Solid Tumors: Phase Ia/b Study
by: Koba Kiknavelidze, PhD, et al.
Published: (2021) -
Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
by: Ding Q, et al.
Published: (2013) -
Blefarite e tricomegalia induzidas pelo cetuximabe Blepharitis and trichomegaly induced by cetuximab
by: Paulo Ricardo Criado, et al.
Published: (2010) -
Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011)